
Convira Pharmaceuticals Private Limited
Pharmaceutical company specializing in manufacturing, distributing, and exporting various drugs and medical preparations.
Pharmaceutical company specializing in manufacturing, distributing, and exporting various drugs and medical preparations.
Convira Pharmaceuticals Private Limited (CPPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 January 2012 and has a history of 13 years and three months. Its registered office is in Kanpur Nagar, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.11 M.
The company currently has active open charges totaling ₹0.95 M. The company has closed loans amounting to ₹2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Sujeet Sahu and Payal Sahu serve as directors at the Company.
Kanpur Nagar, Uttar Pradesh, India
+91-XXXXXXXXXX
U74120UP2012PTC048613
048613
Private Limited Indian Non-Government Company
30 Jan 2012
30 Sep 2024
31 Mar 2024
Unlisted
Roc Kanpur
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sujeet Sahu ![]() | Managing Director | 30-Jan-2012 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Payal Sahu ![]() | Director | 30-Jan-2012 | Current |
Convira Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 18.75% decrease. The company also saw a substantial fall in profitability, with a 56.41% decrease in profit. The company's net worth dipped by a decrease of 1.79%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Convira Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Sujeet Sahu and Payal Sahu are mutual person
₹0.95 M
₹2.00 M
Date | Lender | Amount | Status |
---|---|---|---|
27 Sep 2021 | Others | ₹0.95 M | Open |
27 Jul 2013 | Bank Of India | ₹2.00 M | Satisfied |
Unlock and access historical data on people associated with Convira Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Convira Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Convira Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Convira Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Convira Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur.
A charge with Others amounted to Rs. 0.95 M with Charge ID 100490687 was registered on 27 Sep 2021.
A charge registered on 27 Jul 2013 via Charge ID 10443619 with Bank Of India was fully satisfied on 22 May 2019.
A charge with Bank Of India of Rs. 2.00 M registered on 27 Jul 2013 with Charge ID 10443619 was modified on 06 Dec 2014.
A charge with Bank Of India amounted to Rs. 2.00 M with Charge ID 10443619 was registered on 27 Jul 2013.
Convira Pharmaceuticals Private Limited was incorporated on 30 Jan 2012.
The authorized share capital of Convira Pharmaceuticals Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.11 M.
Currently 2 directors are associated with Convira Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Convira Pharmaceuticals Private Limited is Raman Villa Apartment Flat No. 102 160-E Block Shyam Nagar, India, Kanpur, Uttar Pradesh, 208013.
The corporate identification number (CIN) of Convira Pharmaceuticals Private Limited is U74120UP2012PTC048613 and the company number is 048613 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Convira Pharmaceuticals Private Limited has fallen by -18.75%.
The financial reports for the fiscal year 2023 indicates that The net worth of Convira Pharmaceuticals Private Limited has experienced an downturn of -1.79%.
As per the financial statements for fiscal Year 2023, The total open charges for Convira Pharmaceuticals Private Limited amount to ₹ 0.95 M.
The most recent Balance Sheet for Convira Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
BA